The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Dyne Therapeutics Inc shares valued at $474,045 were sold by Incerti Carlo on Nov 18 ’24. At $28.73 per share, Incerti Carlo sold 16,500 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Rhodes Jason P sold 782 shares, netting a total of over 25,884 in proceeds. Following the sale of shares at $33.10 each, the insider now holds 15,962 shares.
Before that, Incerti Carlo had added 16,500 shares to its account. In a trade valued at $462,000, the Director bought Dyne Therapeutics Inc shares for $28.00 each.
As published in a research note from JP Morgan on October 24, 2024, Dyne Therapeutics Inc [DYN] has been rated down from an Overweight to a Neutral and the price target has been revised to $35 from $43. Analysts at Chardan Capital Markets resumed the stock at ‘”a Buy”‘ outlook in a report released in late May. As of April 30, 2024, Morgan Stanley has initiated its “an Overweight” rating for DYN. Earlier on February 20, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for DYN stock.
Analyzing DYN Stock Performance
During the last five days, there has been a drop of approximately -12.13%. Over the course of the year, Dyne Therapeutics Inc shares have jumped approximately 125.49%. Shares of the company reached a 52-week high of $47.45 on 08/20/24 and a 52-week low of $12.33 on 01/03/24. A 50-day SMA is recorded $32.31, while a 200-day SMA reached $32.33. Nevertheless, trading volume fell to 1.09 million shares from 0.67 million shares the previous day.
Support And Resistance Levels for Dyne Therapeutics Inc (DYN)
According to the 24-hour chart, there is a support level at 29.02, which, if violated, would cause prices to drop to 28.05. In the upper region, resistance lies at 30.62. The next price resistance is at 31.25. RSI (Relative Strength Index) is 47.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.17, which suggests the price will decrease in the coming days. Percent R is at 65.86%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
